Current NDC auxiliary source row compounder:4763

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 73702-211
Product Ndc: 73702-211
Product Ndc Digits: 73702211
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Fentanyl with 0.2% Ropivacaine
Proprietary Name Suffix: [empty]
Nonproprietary Name: Fentanyl with 0.2% Ropivacaine
Dosage Form Name: INJECTION
Route Name: EPIDURAL
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Wells Pharma of Houston
Establishment Name: Wells Pharma of Houston
Establishment Fei: [empty]
Substance Name: ROPIVACAINE HYDROCHLORIDE; FENTANYL
Active Ingredients Info: 2 mg/1 mL; 2 ug/1 mL
History Active Ingredients Raw: ROPIVACAINE HYDROCHLORIDE; FENTANYL
History Active Ingredients Info Raw: 2 mg/1 mL; 2 ug/1 mL
History Dosage Raw: INJECTION
Dea Schedule: CII
Package Ndc Raw: 73702-211-02
Package Ndc: 73702-211-02
Package Ndc Digits: 7370221102
Package Ndc11: 73702021102
Package Description: 100 mL in 1 BAG (73702-211-02)
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:4763
Source Row Number: 4763
Source Row Hash: 505b1b7fb0317407f9e523970e4bd5ee19c1575689bb18e3d39df150ec968b31
Import Run Id: 20261026T055812Z
Loaded At: 2026-10-26 06:02:33

Exact raw FDA source fields#

{
    "ROUTENAME": "EPIDURAL",
    "PRODUCTNDC": "73702-211",
    "DEASCHEDULE": "CII",
    "LABELERNAME": "Wells Pharma of Houston",
    "SUBSTANCENAME": "ROPIVACAINE HYDROCHLORIDE; FENTANYL",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "73702-211-02",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Fentanyl with 0.2% Ropivacaine",
    "REPORTINGPERIOD": "2026-1",
    "NONPROPRIETARYNAME": "Fentanyl with 0.2% Ropivacaine",
    "PACKAGEDESCRIPTION": "100 mL in 1 BAG (73702-211-02) ",
    "ACTIVEINGREDIENTSINFO": "2 mg/1 mL; 2 ug/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:4763
Source Row Number: 4763
Status Scope: package
Lookup Ndc: 73702-211-02
Lookup Ndc Digits: 7370221102
Product Ndc: 73702-211
Product Ndc Digits: 73702211
Package Ndc: 73702-211-02
Package Ndc Digits: 7370221102
Package Ndc11: 73702021102
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 505b1b7fb0317407f9e523970e4bd5ee19c1575689bb18e3d39df150ec968b31
Import Run Id: 20261026T055812Z
Loaded At: 2026-10-26 06:02:33